Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation

Febrile infection-related epilepsy syndrome (FIRES) is a challenging condition with unfavorable outcome in most cases. Preliminary evidence suggests that some interleukins, in particular IL-1 Receptor Antagonist (IL-1RA), could be elevated due to a functional deficiency of anti-inflammatory pathways...

Full description

Bibliographic Details
Main Authors: Marco Perulli, Gianpaolo Cicala, Ida Turrini, Elisa Musto, Michela Quintiliani, Maria Luigia Gambardella, Silvia Maria Pulitanò, Sarah Bompard, Susanna Staccioli, Laura Carmillo, Gabriele Di Sante, Francesco Ria, Chiara Veredice, Ilaria Contaldo, Domenica Battaglia
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Epilepsy & Behavior Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589986422000089
_version_ 1818011513025200128
author Marco Perulli
Gianpaolo Cicala
Ida Turrini
Elisa Musto
Michela Quintiliani
Maria Luigia Gambardella
Silvia Maria Pulitanò
Sarah Bompard
Susanna Staccioli
Laura Carmillo
Gabriele Di Sante
Francesco Ria
Chiara Veredice
Ilaria Contaldo
Domenica Battaglia
author_facet Marco Perulli
Gianpaolo Cicala
Ida Turrini
Elisa Musto
Michela Quintiliani
Maria Luigia Gambardella
Silvia Maria Pulitanò
Sarah Bompard
Susanna Staccioli
Laura Carmillo
Gabriele Di Sante
Francesco Ria
Chiara Veredice
Ilaria Contaldo
Domenica Battaglia
author_sort Marco Perulli
collection DOAJ
description Febrile infection-related epilepsy syndrome (FIRES) is a challenging condition with unfavorable outcome in most cases. Preliminary evidence suggests that some interleukins, in particular IL-1 Receptor Antagonist (IL-1RA), could be elevated due to a functional deficiency of anti-inflammatory pathways. Therefore, treatment strategies acting on innate immunity could represent a targeted treatment.We describe the case of an 11-year-old child with super-refractory status epilepticus (SE), lasting more than two months. After being treated aggressively with antiseizure medications, anesthetics and empiric treatment for autoimmune encephalitis without success, she responded to anakinra and ketogenic diet. Escalation of the therapy was supported by the finding of a very high serum level of IL-1RA. This immunomodulatory approach allowed to discharge the child from intensive care 48 days after the SE onset. After more than one year follow-up the patient has moderate intellectual disability but with good language skills; she is seizure free and without motor deficits.This case suggests that serum IL-1RA serum levels may help to support treatment escalation. Moreover, anakinra and ketogenic diet represent encouraging immunomodulatory strategies which deserve further studies and could potentially have a synergistic effect. Finally, structured neuropsychological testing is an important outcome measure that will help to define the effectiveness of different treatment strategies.
first_indexed 2024-04-14T06:09:40Z
format Article
id doaj.art-aab4a949d4ee43f6bc20cacba6c3157c
institution Directory Open Access Journal
issn 2589-9864
language English
last_indexed 2024-04-14T06:09:40Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Epilepsy & Behavior Reports
spelling doaj.art-aab4a949d4ee43f6bc20cacba6c3157c2022-12-22T02:08:25ZengElsevierEpilepsy & Behavior Reports2589-98642022-01-0118100531Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulationMarco Perulli0Gianpaolo Cicala1Ida Turrini2Elisa Musto3Michela Quintiliani4Maria Luigia Gambardella5Silvia Maria Pulitanò6Sarah Bompard7Susanna Staccioli8Laura Carmillo9Gabriele Di Sante10Francesco Ria11Chiara Veredice12Ilaria Contaldo13Domenica Battaglia14Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy; Neuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Corresponding author at: Child Neurology Unit, Department of Pediatrics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Largo Francesco Vito, 1, 00168 Roma, Italy.Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy; Neuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy; Neuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy; Neuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyNeuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyNeuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyUnità di terapia intensiva pediatrica e trauma center pediatrico, Dipartimento scienze dell’emergenza, anestesiologiche e della rianimazione, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyDipartimento di neuroriabilitazione, IRCCS Ospedale Pediatrico “Bambino Gesù”, Roma, ItalyDipartimento di neuroriabilitazione, IRCCS Ospedale Pediatrico “Bambino Gesù”, Roma, ItalyUnità di Neurologia, Ospedale V. Fazzi, Lecce, ItalySection of Human, Clinical and Forensic Anatomy, Department of Medicine, University of Perugia, Perugia, Italy; Sezione di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, ItalyDipartimento di Medicina e Chirurgia Traslazionali, Universià Cattolica del S. Cuore IRCCS Policlinico Universitario A. Gemelli, Roma, ItalyDipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy; Neuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyNeuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy; Neuropsichiatria Infantile, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyFebrile infection-related epilepsy syndrome (FIRES) is a challenging condition with unfavorable outcome in most cases. Preliminary evidence suggests that some interleukins, in particular IL-1 Receptor Antagonist (IL-1RA), could be elevated due to a functional deficiency of anti-inflammatory pathways. Therefore, treatment strategies acting on innate immunity could represent a targeted treatment.We describe the case of an 11-year-old child with super-refractory status epilepticus (SE), lasting more than two months. After being treated aggressively with antiseizure medications, anesthetics and empiric treatment for autoimmune encephalitis without success, she responded to anakinra and ketogenic diet. Escalation of the therapy was supported by the finding of a very high serum level of IL-1RA. This immunomodulatory approach allowed to discharge the child from intensive care 48 days after the SE onset. After more than one year follow-up the patient has moderate intellectual disability but with good language skills; she is seizure free and without motor deficits.This case suggests that serum IL-1RA serum levels may help to support treatment escalation. Moreover, anakinra and ketogenic diet represent encouraging immunomodulatory strategies which deserve further studies and could potentially have a synergistic effect. Finally, structured neuropsychological testing is an important outcome measure that will help to define the effectiveness of different treatment strategies.http://www.sciencedirect.com/science/article/pii/S2589986422000089FIRESNORSEInterleukinAnakinraKetogenic diet
spellingShingle Marco Perulli
Gianpaolo Cicala
Ida Turrini
Elisa Musto
Michela Quintiliani
Maria Luigia Gambardella
Silvia Maria Pulitanò
Sarah Bompard
Susanna Staccioli
Laura Carmillo
Gabriele Di Sante
Francesco Ria
Chiara Veredice
Ilaria Contaldo
Domenica Battaglia
Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation
Epilepsy & Behavior Reports
FIRES
NORSE
Interleukin
Anakinra
Ketogenic diet
title Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation
title_full Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation
title_fullStr Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation
title_full_unstemmed Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation
title_short Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation
title_sort fighting autoinflammation in fires the role of interleukins and early immunomodulation
topic FIRES
NORSE
Interleukin
Anakinra
Ketogenic diet
url http://www.sciencedirect.com/science/article/pii/S2589986422000089
work_keys_str_mv AT marcoperulli fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT gianpaolocicala fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT idaturrini fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT elisamusto fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT michelaquintiliani fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT marialuigiagambardella fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT silviamariapulitano fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT sarahbompard fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT susannastaccioli fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT lauracarmillo fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT gabrieledisante fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT francescoria fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT chiaraveredice fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT ilariacontaldo fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation
AT domenicabattaglia fightingautoinflammationinfirestheroleofinterleukinsandearlyimmunomodulation